alexa A Case of Urachal Carcinoma
ISSN: 2168-9857

Medical & Surgical Urology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

A Case of Urachal Carcinoma

Ryan Griffin1,2, Laura Alder2, Brian Baksa2, Brendon Keith2, Do Young Kim2 and Marc R. Matrana1,2*

1Department of Hematology and Oncology, Ochsner Cancer Institute, New Orleans, LA, USA

2The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA

*Corresponding Author:
Marc R. Matrana
MD, MSc, Third Floor, Benson Cancer Center
Ochsner Clinic Foundation
1514 Jefferson Highway
New Orleans, LA 70121, USA
Tel: +(504) 842-3910
E-mail: [email protected]

Received date: December 31, 2015 Accepted date: February 01, 2016 Published date: February 08, 2016

Citation: Griffin R, Alder L, Baksa B, Keith B, Kim DY, et al. (2016) A Case of Urachal Carcinoma. Med Surg Urol 5:158. doi: 10.4172/2168-9857.1000158

Copyright: © 2016 Griffin R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Urachal carcinoma is a rare, non-urothelial carcinoma that represents less than one percent of all bladder cancers. We present the case of a 58-year-old man who presented with the acute onset of painless hematuria. Cystoscopy revealed a bladder mass, and subsequent biopsy of a liver mass confirmed the diagnosis of metastatic urachal adenocarcinoma. The patient initially underwent a chemotherapeutic regimen of 5-fluorouracil, leucovorin, gemcitabine, and cisplatin (GEM-FLP) given every four weeks. Our case illustrates the importance of recognizing and diagnosing urachal carcinoma correctly since the therapeutic options differ compared to traditional urothelial cancers.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords